A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia

PHASE1

Phase

COMPLETED

Status

Enrollment

INDUSTRY

Sponsor class

Conditions

DRUG: Dutasteride (0.5mg, fasted state)
DRUG: Dutasteride (0.5mg, fed state)
DRUG: Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state)
DRUG: Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state)
DRUG: Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state)
DRUG: Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fed state)
DRUG: Harnal-D Tablets with water (fasted state)
DRUG: Harnal-D Tablets with water (fed state)
DRUG: Harnal-D tablets without water (fasted state)

GlaxoSmithKline